Michael Tuttle, MD, endocrinologist Memorial Sloan Kettering (MSK), discusses best management approaches to radioactive iodine treatment in patients with radioiodine avid distant metastases from differentiated thyroid cancer.
Michael Tuttle, MD
Articles by Michael Tuttle, MD
Latest Updated Articles
Dr. Michael Tuttle on Dosimetry Versus Empiric Dosing Radioactive Iodine TreatmentPublished: October 23rd 2015 | Updated: